Anaphylaxis Market Forecast Highlights A $5.14 Billion Opportunity For Industry Participants
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Anaphylaxis Market Size Forecast: How Big Could The Market Get By 2030?
The anaphylaxis market has shown significant expansion in recent years. It is anticipated to increase from $3.5 billion in 2025 to $3.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to factors such as the increasing occurrence of food and drug allergies, enhanced diagnosis of allergic conditions, the accessibility of emergency epinephrine treatments, heightened public health awareness, and the implementation of standardized treatment guidelines.
The anaphylaxis market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $5.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This projected growth during the forecast period is primarily driven by improved access to emergency allergy care, a surging demand for portable treatment options, the expansion of specialized allergy services, an increasing emphasis on patient education initiatives, and greater investment in allergy management infrastructure. Key developments shaping this period include the increased availability of epinephrine auto-injectors, a heightened understanding of severe allergic reactions, a growing focus on emergency readiness, the broadening scope of allergy diagnosis and monitoring, and an enhanced commitment to rapid response protocols.
Get A Free Sample Report With In-Depth Market Insights:
Anaphylaxis Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of food allergies is anticipated to fuel expansion in the anaphylaxis market. These allergies represent immune system responses initiated by particular foods, leading to symptoms that vary from minor to critical, encompassing potentially fatal anaphylaxis. The uptick in food allergy cases stems from elements like evolving dietary patterns, environmental factors, and enhanced understanding along with better diagnostic methods. Crucial and life-saving, anaphylaxis treatment offers rapid intervention for individuals with food allergies, quickly counteracting severe allergic responses. It alleviates symptoms like swelling, respiratory distress, and decreased blood pressure, ensuring immediate stability and averting potentially deadly results, simultaneously equipping patients to act promptly during subsequent allergic episodes. As an illustration, figures from September 2024 by the World Health Organization (WHO), a United Nations (UN) body situated in Switzerland, indicate that approximately 220 million individuals worldwide suffer from food allergies. It is possible for a single food item to contain several allergens, and people can also have sensitivities to multiple kinds of food. Furthermore, the Patterns and Prevalence of Adult Food Allergy (PAFA) report, released in May 2024 by the Food Standards Agency (FSA), a UK-based non-ministerial department, revealed that over 30% of adults experienced adverse reactions linked to food, with clinical evaluations verifying food allergies in roughly 6% of UK adults, which translates to around 2.4 million individuals. Consequently, the increasing occurrence of food allergies is a key factor propelling the expansion of the anaphylaxis market.
Anaphylaxis Market Segment Landscape And Growth Outlook
The anaphylaxis market covered in this report is segmented –
1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class
2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration
3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications
Subsegments:
1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials
2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists
4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers
Anaphylaxis Market Industry Trends: What’s Reshaping Demand?
Leading companies active in the anaphylaxis market are concentrating on developing advanced epinephrine nasal sprays, which allow for faster, more efficient drug delivery during urgent situations. An epinephrine nasal spray is a medical device designed to administer epinephrine (adrenaline) through the nasal passages for the treatment of severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced the approval of Neffy (epinephrine nasal spray) by the Food and Drug Administration, a US-based government agency, positioning it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray offers a non-invasive option compared to traditional epinephrine autoinjectors, potentially providing a more accessible choice for emergency care. Neffy aims to improve patient compliance by eliminating the need for needles while still delivering rapid, life-saving epinephrine during severe allergic reactions.
Anaphylaxis Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics
View The Full Anaphylaxis Market Report:
Anaphylaxis Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
